75A50126C00004
Definitive Contract
Overview
Government Description
Late-stage development, FDA marketing authorization, procurement, and stockpile of antibiotics for the treatment of drug-resistant secondary bacterial infections and/or the treatment or pep of infections caused by biothreat pathogens. Includes advancing antibiotics for hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) and bloodstream infections (BSI), as well as post-exposure prophylaxis and/or treatment of biothreat pathogens. Activities involve domestic drug substance manufacturing and fill/finish drug product manufacturing, with vendors required to have existing domestic capabilities or a plan to onshore manufacturing. Work may be performed at responder facilities or subcontracted to commercial laboratories, contract research organizations, or contract manufacturing organizations.
Awardee
Awarding / Funding Agency
Place of Performance
Florham Park, NJ 7932 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
240
Shionogi was awarded
Definitive Contract 75A50126C00004 (75A501-26-C-00004)
for Late-Stage Antibiotic Development, FDA Authorization, Procurement, and Stockpile (HABP/VABP, BSI, PEP, Biothreat Pathogens)
worth up to $481,678,318
by the HHS Office of the Assistant Secretary for Preparedness and Response
in April 2026.
The contract
has a duration of 10 years and
was awarded
through solicitation Pre Solicitation - Antibiotic for Treatment of Bacterial Pneumonia or Bloodstream Infections
full & open
with
NAICS 541714 and
PSC AN13
via direct negotiation acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $362,517,627.
Status
(Open)
Last Modified 4/6/26
Period of Performance
4/6/26
Start Date
3/10/36
Current End Date
3/10/36
Potential End Date
Obligations and Backlog
$119.2M
Total Obligated
$119.2M
Current Award
$481.7M
Potential Award
$0.0
Funded Backlog
$362.5M
Total Backlog
Award Hierarchy
Definitive Contract
75A50126C00004
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for 75A50126C00004
People
Suggested agency contacts for 75A50126C00004
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Yes
Business Size Determination
Large Business
Awardee UEI
V8H8DT6RCHW6
Awardee CAGE
37UN1
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsveronicastroud
Last Modified By
hhseringreninger1
Approved By
hhseringreninger1
Legislative
Legislative Mandates
None Applicable
Performance District
NJ-11
Senators
Robert Menendez
Cory Booker
Cory Booker
Representative
Mikie Sherrill
Modified: 4/6/26